BTC Health Limited (BTC.AX)
AUD 0.05
(-8.0%)
AUD 0.05
(-8.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.05 Million AUD | 110.38% |
| 2023 | -10.16 Million AUD | -1665.01% |
| 2022 | -576.07 Thousand AUD | -47.08% |
| 2021 | -391.68 Thousand AUD | -573.83% |
| 2020 | -283.03 Thousand AUD | 18.44% |
| 2019 | -692.74 Thousand AUD | 90.82% |
| 2018 | -466.01 Thousand AUD | -242.38% |
| 2017 | -516.52 Thousand AUD | 125.25% |
| 2016 | -170.78 Thousand AUD | 196.41% |
| 2015 | -207.01 Thousand AUD | -94.81% |
| 2014 | -151 Thousand AUD | 1339.53% |
| 2013 | -122.69 Thousand AUD | -92.43% |
| 2012 | -302.99 Thousand AUD | -33.59% |
| 2011 | -894 Thousand AUD | -57.95% |
| 2010 | -565 Thousand AUD | 246.16% |
| 2009 | -508 Thousand AUD | -258.84% |
| 2008 | -7.37 Million AUD | 16.75% |
| 2007 | -825 Thousand AUD | 5.29% |
| 2006 | -397 Thousand AUD | 9.17% |
| 2005 | -1.57 Million AUD | -215.66% |
| 2004 | 5.61 Million AUD | 213.9% |
| 2003 | -1.04 Million AUD | -12.88% |
| 2002 | -924 Thousand AUD | 2.01% |
| 2001 | -943 Thousand AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 323.52 Million AUD | 0.0% |
| 2024 Q2 | -21.73 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 110.38% |
| 2023 FY | - AUD | -1665.01% |
| 2023 Q4 | -9.64 Million AUD | 0.0% |
| 2023 Q2 | -38.3 Thousand AUD | 0.0% |
| 2022 FY | - AUD | -47.08% |
| 2022 Q4 | -219.22 Thousand AUD | 0.0% |
| 2022 Q2 | -356.86 Thousand AUD | 0.0% |
| 2021 FY | - AUD | -573.83% |
| 2021 Q4 | -212.74 Thousand AUD | 0.0% |
| 2021 Q2 | -34.3 Thousand AUD | 0.0% |
| 2020 Q4 | -12.3 Thousand AUD | 0.0% |
| 2020 FY | - AUD | 18.44% |
| 2020 Q2 | -45.82 Thousand AUD | 0.0% |
| 2019 Q4 | -29.1 Thousand AUD | 0.0% |
| 2019 FY | - AUD | 90.82% |
| 2019 Q2 | -42.16 Thousand AUD | 0.0% |
| 2018 FY | - AUD | -242.38% |
| 2018 Q2 | -822.29 Thousand AUD | 0.0% |
| 2018 Q4 | 46.3 Thousand AUD | 0.0% |
| 2017 Q2 | -28.61 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 125.25% |
| 2017 Q4 | -457.00 AUD | 0.0% |
| 2016 Q4 | -700.35 Thousand AUD | 0.0% |
| 2016 Q2 | -25.28 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 196.41% |
| 2015 FY | - AUD | -94.81% |
| 2015 Q4 | -285.33 Thousand AUD | 0.0% |
| 2015 Q2 | -14.66 Thousand AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 1339.53% |
| 2014 Q2 | -1.73 Million AUD | 0.0% |
| 2013 Q4 | 9599.00 AUD | 107.65% |
| 2013 Q2 | -279.16 Thousand AUD | 39.97% |
| 2013 Q3 | -125.43 Thousand AUD | 55.07% |
| 2013 Q1 | -465.04 Thousand AUD | 0.0% |
| 2013 FY | - AUD | -92.43% |
| 2012 Q4 | -465.04 Thousand AUD | 0.0% |
| 2012 Q2 | -465.04 Thousand AUD | 46.78% |
| 2012 Q1 | -873.75 Thousand AUD | 0.0% |
| 2012 FY | - AUD | -33.59% |
| 2012 Q3 | -465.04 Thousand AUD | 0.0% |
| 2011 Q3 | -873.75 Thousand AUD | 0.0% |
| 2011 FY | - AUD | -57.95% |
| 2011 Q4 | -873.75 Thousand AUD | 0.0% |
| 2011 Q2 | -873.75 Thousand AUD | 38.76% |
| 2011 Q1 | -1.42 Million AUD | 0.0% |
| 2010 Q2 | -1.42 Million AUD | -31.71% |
| 2010 Q3 | -1.42 Million AUD | 0.0% |
| 2010 Q4 | -1.42 Million AUD | 0.0% |
| 2010 FY | - AUD | 246.16% |
| 2010 Q1 | -1.08 Million AUD | 0.0% |
| 2009 Q4 | -1.08 Million AUD | 0.0% |
| 2009 Q1 | -1.84 Million AUD | 0.0% |
| 2009 Q2 | -1.08 Million AUD | 41.23% |
| 2009 Q3 | -1.08 Million AUD | 0.0% |
| 2009 FY | - AUD | -258.84% |
| 2008 Q1 | -206.25 Thousand AUD | 0.0% |
| 2008 Q4 | -1.84 Million AUD | 0.0% |
| 2008 Q3 | -1.84 Million AUD | 0.0% |
| 2008 FY | - AUD | 16.75% |
| 2008 Q2 | -1.84 Million AUD | -793.7% |
| 2007 Q4 | -206.25 Thousand AUD | 0.0% |
| 2007 Q3 | -206.25 Thousand AUD | 0.0% |
| 2007 Q2 | -206.25 Thousand AUD | -107.81% |
| 2007 Q1 | -99.25 Thousand AUD | 0.0% |
| 2007 FY | - AUD | 5.29% |
| 2006 Q2 | -99.25 Thousand AUD | 85.47% |
| 2006 Q3 | -99.25 Thousand AUD | 0.0% |
| 2006 FY | - AUD | 9.17% |
| 2006 Q4 | -99.25 Thousand AUD | 0.0% |
| 2006 Q1 | -683.25 Thousand AUD | 0.0% |
| 2005 Q1 | 297 Thousand AUD | 0.0% |
| 2005 Q4 | -683.25 Thousand AUD | 0.0% |
| 2005 FY | - AUD | -215.66% |
| 2005 Q3 | -683.25 Thousand AUD | 0.0% |
| 2005 Q2 | -683.25 Thousand AUD | -330.05% |
| 2004 Q1 | -1750.00 AUD | 0.0% |
| 2004 Q2 | 297 Thousand AUD | 17071.43% |
| 2004 FY | - AUD | 213.9% |
| 2004 Q4 | 297 Thousand AUD | 0.0% |
| 2004 Q3 | 297 Thousand AUD | 0.0% |
| 2003 Q3 | -1750.00 AUD | 0.0% |
| 2003 FY | - AUD | -12.88% |
| 2003 Q1 | 50.25 Thousand AUD | 0.0% |
| 2003 Q2 | -1750.00 AUD | -103.48% |
| 2003 Q4 | -1750.00 AUD | 0.0% |
| 2002 Q1 | 376.25 Thousand AUD | 0.0% |
| 2002 Q4 | 50.25 Thousand AUD | 0.0% |
| 2002 FY | - AUD | 2.01% |
| 2002 Q2 | 50.25 Thousand AUD | -86.64% |
| 2002 Q3 | 50.25 Thousand AUD | 0.0% |
| 2001 Q4 | 376.25 Thousand AUD | 0.0% |
| 2001 Q2 | 376.25 Thousand AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q3 | 376.25 Thousand AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AdAlta Limited | -5.3 Million AUD | 119.901% |
| Acrux Limited | -7.93 Million AUD | 113.306% |
| Race Oncology Limited | -14.2 Million AUD | 107.43% |
| Biome Australia Limited | -1.57 Million AUD | 166.864% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 107.581% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 109.339% |
| CSL Limited | 4.73 Billion AUD | 99.978% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 102.364% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 97.965% |
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 89.829% |
| Hexima Limited | -995.54 Thousand AUD | 206.001% |
| Immutep Limited | -42.87 Million AUD | 102.461% |
| Memphasys Limited | -3.3 Million AUD | 131.904% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 99.47% |
| Noxopharm Limited | -5.94 Million AUD | 117.749% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 114.686% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 102.326% |
| Starpharma Holdings Limited | -12.57 Million AUD | 108.391% |
| Tissue Repair Ltd | -5.77 Million AUD | 118.273% |
| Biotron Limited | -5.04 Million AUD | 120.938% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 105.392% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 172.445% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 135.472% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 102.896% |
| Patrys Limited | -3.49 Million AUD | 130.219% |
| Orthocell Limited | -11.68 Million AUD | 109.034% |
| Imugene Limited | -147.97 Million AUD | 100.713% |
| PYC Therapeutics Limited | -38.11 Million AUD | 102.769% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 113.38% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 110.606% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 111.947% |
| Nanollose Limited | -1.14 Million AUD | 191.932% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | 246.478% |
| NeuroScientific Biopharmaceuticals Limited | -1.79 Million AUD | 158.748% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 123.144% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 137.447% |
| Nyrada Inc. | -4.59 Million AUD | 122.96% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 95.405% |
| Dimerix Limited | -24.95 Million AUD | 104.228% |
| PharmAust Limited | -9.45 Million AUD | 111.165% |
| AnteoTech Limited | -11.57 Million AUD | 109.12% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 101.635% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 104.942% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 132.545% |
| Actinogen Medical Limited | -12.92 Million AUD | 108.167% |
| Immuron Limited | -6.19 Million AUD | 117.042% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 155.612% |